Diantha Duvall - Net Worth and Insider Trading
Diantha Duvall Net Worth
The estimated net worth of Diantha Duvall is at least $223,405 dollars as of 2024-11-05. Diantha Duvall is the Chief Accounting Officer of Bioverativ Inc and owns about 2,128 shares of Bioverativ Inc (BIVV) stock worth over $223,397. Diantha Duvall is also the CHIEF FINANCIAL OFFICER of Genocea Biosciences Inc and owns about 76,743 shares of Genocea Biosciences Inc (GNCAQ) stock worth over $8. Details can be seen in Diantha Duvall's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Diantha Duvall has not made any transactions after 2022-05-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Diantha Duvall
Diantha Duvall Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Diantha Duvall owns 4 companies in total, including Genocea Biosciences Inc (GNCAQ) , Bioverativ Inc (BIVV) , and Curis Inc (CRIS) among others .
Click here to see the complete history of Diantha Duvall’s form 4 insider trades.
Insider Ownership Summary of Diantha Duvall
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GNCAQ | Genocea Biosciences Inc | 2022-05-26 | CHIEF FINANCIAL OFFICER |
| BIVV | Bioverativ Inc | 2018-03-08 | Chief Accounting Officer |
| CRIS | Curis Inc | 2023-01-20 | CFO |
 | | 2019-03-05 | CHIEF FINANCIAL OFFICER |
Diantha Duvall Latest Holdings Summary
Diantha Duvall currently owns a total of 2 stocks. Among these stocks, Diantha Duvall owns 2,128 shares of Bioverativ Inc (BIVV) as of June 28, 2017, with a value of $223,397 and a weighting of 100%. Diantha Duvall also owns 76,743 shares of Genocea Biosciences Inc (GNCAQ) as of May 26, 2022, with a value of $8 and a weighting of 0%.
Latest Holdings of Diantha Duvall
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BIVV | Bioverativ Inc | 2017-06-28 | 2,128 | 104.98 | 223,397 |
| GNCAQ | Genocea Biosciences Inc | 2022-05-26 | 76,743 | 0.00 | 8 |
Holding Weightings of Diantha Duvall
Diantha Duvall Form 4 Trading Tracker
According to the SEC Form 4 filings, Diantha Duvall has made a total of 0 transactions in Bioverativ Inc (BIVV) over the past 5 years. The most-recent trade in Bioverativ Inc is the sale of 818 shares on June 28, 2017, which brought Diantha Duvall around $49,465.
According to the SEC Form 4 filings, Diantha Duvall has made a total of 2 transactions in Genocea Biosciences Inc (GNCAQ) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Genocea Biosciences Inc is the sale of 24,407 shares on May 26, 2022, which brought Diantha Duvall around $1,953.
Insider Trading History of Diantha Duvall
- 1
Diantha Duvall Trading Performance
Diantha Duvall Ownership Network
Ownership Network List of Diantha Duvall
Ownership Network Relation of Diantha Duvall
Diantha Duvall Owned Company Details
What does Genocea Biosciences Inc do?
Who are the key executives at Genocea Biosciences Inc?
Diantha Duvall is the CHIEF FINANCIAL OFFICER of Genocea Biosciences Inc. Other key executives at Genocea Biosciences Inc include CHIEF LEGAL & COMPLIANCE OFF Jacquelyn L Sumer , director & President and CEO William D Clark , and 10 percent owner New Enterprise Associates 16, L.p. .
Genocea Biosciences Inc (GNCAQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GNCAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GNCAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Genocea Biosciences Inc (GNCAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Genocea Biosciences Inc Insider Transactions
Diantha Duvall Mailing Address
Above is the net worth, insider trading, and ownership report for Diantha Duvall. You might contact Diantha Duvall via mailing address: C/o Genocea Biosciences, Inc., 100 Acorn Park Drive 5th Floor, Cambridge Ma 02140.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
